<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Simparica Trio now licensed for lungworm</title><link>/b/veterinary-news/posts/simparica-trio-now-licensed-for-lungworm</link><description> Zoetis has announced that Simparica Trio is now licensed for the treatment of Angiostrongylus vasorum, aka lungworm in dogs. 
 This, the company says, makes Simparica Trio the only oral moxidectin that is licensed to treat A.vasorum in dogs in the UK</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>